# FDA recall D-1052-2014

> **NuVision Pharmacy, Inc.** · Class I · drug recall initiated 2013-04-15.

## Product

Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244

## Reason for recall

Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1052-2014
- **Recalling firm:** NuVision Pharmacy, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-15
- **Report date:** 2014-02-05
- **Termination date:** 2017-02-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dallas, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1052-2014

## Citation

> AI Analytics. FDA recall D-1052-2014. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1052-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*